MedTrace Logo

Pharmacokinetic (PK)Research on Chinese Children of Hemophilia

NCT03622476 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2018-08-14

No results posted yet for this study

Summary

The study start on June 30, 2018. The Severe(F Ⅷ\<1%) hemophilia A children without F Ⅷ inhibitor combining were recruited to Test the concentration of the drug in the blood to provide better treatment.

Conditions

  • Pharmacokinetics

Interventions

DRUG

concentrated FVIII

Intervention if the assessment considers that the treatment is inadequate

Sponsors & Collaborators

  • Beijing Children's Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
14 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2021-07-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622476 on ClinicalTrials.gov